Isoflurane
- Generic Name
- Isoflurane
- Brand Names
- Forane, Terrell
- Drug Type
- Small Molecule
- Chemical Formula
- C3H2ClF5O
- CAS Number
- 26675-46-7
- Unique Ingredient Identifier
- CYS9AKD70P
- Background
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
- Indication
For induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Induction and Maintenance of General Anesthesia
Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI
- Conditions
- Interventions
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- State University of New York at Buffalo
- Target Recruit Count
- 6
- Registration Number
- NCT02111447
- Locations
- 🇺🇸
Women and Chidren's Hospital Of Buffalo, Buffalo, New York, United States
AnaConDa Long Term Sedation Study
- Conditions
- Interventions
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 60
- Registration Number
- NCT01983800
- Locations
- 🇨🇦
Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
PaNeX: Partial Nephrectomy Under Xenon
- Conditions
- Interventions
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2016-02-18
- Lead Sponsor
- RWTH Aachen University
- Target Recruit Count
- 46
- Registration Number
- NCT01839084
- Locations
- 🇩🇪
Department of Anesthesiology, University Hospital Aachen, Aachen, NRW, Germany
The Effects of Anesthesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.
- Conditions
- Interventions
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 14
- Registration Number
- NCT01772537
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia
- First Posted Date
- 2012-07-13
- Last Posted Date
- 2015-08-04
- Lead Sponsor
- Duke University
- Target Recruit Count
- 105
- Registration Number
- NCT01640275
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)
- Conditions
- Interventions
- First Posted Date
- 2012-05-18
- Last Posted Date
- 2014-01-29
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 30
- Registration Number
- NCT01601795
- Locations
- 🇨🇭
University Hospital of Basel, Basel, Switzerland
Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-07-19
- Last Posted Date
- 2018-04-24
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT01397331
- Locations
- 🇮🇱
Department of Anesthesia and Intensive Care, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project
- Conditions
- Interventions
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 1584
- Registration Number
- NCT01379664
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Ventilatory Effect on Speed of Anesthesia Under Various Inhaled Anesthetics
- Conditions
- Interventions
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2012-08-13
- Lead Sponsor
- DongGuk University
- Target Recruit Count
- 36
- Registration Number
- NCT01171833
Isoflurane Preconditioning for Liver Resections
- First Posted Date
- 2009-12-14
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 8
- Registration Number
- NCT01031550
- Locations
- 🇺🇸
UMDNJ-University Hospital, Newark, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.